CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-811X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion ; volume:15 ; number:1 ; day:9 ; month:11 ; year:2017 ; pages:1-10 ; date:12.2017
Cell communication and signaling ; 15, Heft 1 (9.11.2017), 1-10, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Ouhtit, Allal
- Beteiligte Personen und Organisationen
-
Abdraboh, Mohammed E.
Hollenbach, Andrew D.
Zayed, Hatem
Raj, Madhwa H. G.
SpringerLink (Online service)
- DOI
-
10.1186/s12964-017-0200-3
- URN
-
urn:nbn:de:1111-201801077214
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ouhtit, Allal
- Abdraboh, Mohammed E.
- Hollenbach, Andrew D.
- Zayed, Hatem
- Raj, Madhwa H. G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells
Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44
CD44 as a tumor biomarker and therapeutic target
INPP4B suppresses prostate cancer cell invasion
Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Ligand-specific recruitment of CD44 isoforms in EGFR signaling
The role of CD44 in Wnt/ß-catenin signaling
Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines
ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling
LNK suppresses interferon signaling in melanoma
Signal transduction during CNS invasion by Listeria monocytogenes and the role of CD44 in the invasion
RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells
Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44
CD44 as a tumor biomarker and therapeutic target
INPP4B suppresses prostate cancer cell invasion
Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Ligand-specific recruitment of CD44 isoforms in EGFR signaling
The role of CD44 in Wnt/ß-catenin signaling
Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines
ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling
LNK suppresses interferon signaling in melanoma
Signal transduction during CNS invasion by Listeria monocytogenes and the role of CD44 in the invasion
RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells
Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44
CD44 as a tumor biomarker and therapeutic target
INPP4B suppresses prostate cancer cell invasion
Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Ligand-specific recruitment of CD44 isoforms in EGFR signaling
The role of CD44 in Wnt/ß-catenin signaling
Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines
ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling
LNK suppresses interferon signaling in melanoma